Skip to main content
Features
Integrations
Data
Pricing
Log In
Start Free Trial
Features
Integrations
Data
Pricing
Log In
Start Free Trial
Lorenz Bankel
Sign up to set email alerts
30
Publications
278
Citation Statements Received
546
Citation Statements Given
How they've been cited
388
4
274
0
How they cite others
903
22
523
1
Affiliations
University Hospital of Zurich
,
University of Zurich
Publications
Order By: Most citations
Reversal of tumor acidosis by systemic buffering reactivates NK cells to express IFN‐γ and induces NK cell‐dependent lymphoma control without other immunotherapies
Pötzl
1
,
Roser
2
,
Bankel
3
et al.
2017
Intl Journal of Cancer
Abstract
Show
119
1
97
0
Get access via publisher
Add to collection
Cite
Local delivery of CAR T cells targeting fibroblast activation protein is safe in patients with pleural mesothelioma: first report of FAPME, a phase I clinical trial
Hiltbrunner
1
,
Britschgi
2
,
Schuberth
3
et al.
2021
Annals of Oncology
93
1
47
0
Get access via publisher
Add to collection
Cite
A phase I clinical trial of malignant pleural mesothelioma treated with locally delivered autologous anti-FAP-targeted CAR T-cells
Britschgi
1
,
Hiltbrunner
2
,
Bankel
3
et al.
2019
Annals of Oncology
57
0
40
0
Get access via publisher
Add to collection
Cite
A Novel CXCL10-Based GPI-Anchored Fusion Protein as Adjuvant in NK-Based Tumor Therapy
Muenchmeier
1
,
Boecker
2
,
Bankel
3
et al.
2013
PLoS ONE
Abstract
Show
18
0
22
0
Get access via publisher
Add to collection
Cite
Unravelling homologous recombination repair deficiency and therapeutic opportunities in soft tissue and bone sarcoma
Planas‐Paz
1
,
Pliego‐Mendieta
2
,
Hagedorn
3
et al.
2023
EMBO Mol Med
Abstract
Show
23
1
20
0
Get access via publisher
Add to collection
Cite
18F-FET PET for Diagnosis of Pseudoprogression of Brain Metastases in Patients With Non–Small Cell Lung Cancer
Akhoundova
1
,
Hiltbrunner
2
,
Mader
3
et al.
2019
Clin Nucl Med
Abstract
Show
25
0
19
0
Get access via publisher
Add to collection
Cite
Molecular and functional landscape of malignant serous effusions for precision oncology
Wegmann
1
,
Bankel
2
,
Festl
3
et al.
2024
Nat Commun
Abstract
Show
15
0
16
0
Get access via publisher
Add to collection
Cite
Comprehensive Statistical Exploration of Prognostic (Bio-)Markers for Responses to Immune Checkpoint Inhibitor in Patients with Non-Small Cell Lung Cancer
Hiltbrunner
1
,
Spohn
2
,
Wechsler
3
et al.
2021
Cancers
Abstract
Show
11
0
6
0
Get access via publisher
Add to collection
Cite
1
2
3
4
